Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 29, 2015ACS Chemical Neuroscience

Effects of Bioisosteric Fluorine in Synthetic Cannabinoid Designer Drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135

View Full Paper
Ask AI
Bookmark
Share

Authors

SBSamuel D. BanisterThe University of SydneyJSJordyn StuartThe University of SydneyRKRichard C. KevinThe University of Sydney

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Banister et al. (2015) studied this question.

synapsesocial.com/papers/6a62c6d20582df600cc3e2behttps://doi.org/10.1021/acschemneuro.5b00107
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Bioisosteric Fluorine in the Clandestine Design of Synthetic Cannabinoids2014 · 34 citations
  2. 2Expression of G protein-coupled receptors and related proteins in HEK293, AtT20, BV2, and N18 cell lines as revealed by microarray analysis2011 · 445 citations
  3. 3A short history of SHELX2007 · 87,955 citations
  4. 4Analgesic, Heart Rate, and Temperature Effects of Δ 8 -THC during Acute and Chronic Administration to Conscious Rats2008 · 18 citations
  5. 5Study on the phase I metabolism of novel synthetic cannabinoids, APICA and its fluorinated analogue2014 · 31 citations